{
    "clinical_study": {
        "@rank": "149641", 
        "arm_group": [
            {
                "arm_group_label": "Drug Eluting Stent", 
                "arm_group_type": "Experimental", 
                "description": "Stent Inspiron with Sirolimus"
            }, 
            {
                "arm_group_label": "Drug eluting stent", 
                "arm_group_type": "Active Comparator", 
                "description": "Stent Biomatrix Flex with biolimus"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of this study is to evaluate the effectiveness of stent Inspiron \u2122\n      sirolimus-eluting and coating the abluminal biodegradable stent Biomatrix Flex \u2122 lesions in\n      native coronary arteries."
        }, 
        "brief_title": "DESTINY TRIAL (Inspiron x Biomatrix)", 
        "completion_date": {
            "#text": "February 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a study of non-inferiority, multicentre, prospective, randomized into two treatment\n      arms: I) Inspiron \u2122 stent eluting sirolimus or II) \u2122 Biomatrix stent eluting biolimus. Are a\n      total of 165 randomized patients.\n\n      Patients will be followed for 60 months after the procedure. All new patients will be\n      undergoing angiography for evaluation at 9 months. A subgroup of 60 patients will be\n      evaluated with volumetric intravascular ultrasound at 9 months. Also, a subgroup of 21\n      patients will be evaluated with optical coherence tomography at the end of the index\n      procedure and 9 months. It is anticipated that the total study duration is 72 months: 12\n      months to complete the admission of patients and 60 months of follow-up."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age > 18 years;\n\n          2. Symptomatic ischemic heart disease and / or objective evidence of myocardial ischemia\n             with one or two target lesions located in different epicardial vessels;\n\n          3. A(s) lesion(s) to target(m) must be:\n\n               1. Again (not restenotic);\n\n               2. Located in a native coronary artery diameter from 2.5 to 3.5 mm (visual);\n\n               3. Can be treated with a single stent up to 29 mm in length;\n\n               4. Obstruction with stenosis > 50% diameter (visual);\n\n          4. Acceptable candidate for CABG;\n\n          5. The patient will be informed of the nature of the study, agree with their rules and\n             provide a written informed consent approved by the local Ethics Committee.\n\n        Exclusion Criteria:\n\n          1. Women of childbearing age with no history of surgical sterilization;\n\n          2. Myocardial infarction with Q wave occurred in the last 48 hours before the index\n             procedure;\n\n          3. Myocardial infarction with or without Q wave with cardiac markers even at high\n             levels;\n\n          4. Ejection fraction < 30%;\n\n          5. Impaired renal function (creatinine> 2.0 mg / dl) or calculated creatinine clearance\n             < 60 ml / min;\n\n          6. Platelet count <100,000 cells/mm3 or > 700,000 cells/mm3;\n\n          7. Total leukocyte count <3000 cells/mm3;\n\n          8. Documented or suspected liver disease (including laboratory evidence of hepatitis);\n\n          9. Heart transplant recipient;\n\n         10. Known allergies to aspirin, clopidogrel, ticlopidine, paclitaxel, sirolimus, heparin\n             or stainless steel;\n\n         11. Patient with a life expectancy less than 12 months;\n\n         12. Any significant medical condition which in the opinion of the investigator would\n             interfere with the ideal of patient participation in this study;\n\n         13. Participation in other research in the last 12 months, unless there is direct benefit\n             to the research subject;\n\n         14. Coronary angioplasty (with or without stenting) for less than 6 months anywhere in\n             the target vessel;\n\n         15. Coronary angioplasty (with or without stenting) prior to any time in that segment\n             Diste less than 5 mm (proximal or distal) of the lesion;\n\n         16. Coronary angioplasty (with or without stenting) scheduled in the first 12 months\n             after the index procedure in any segment of the target vessel.\n\n        EXCLUSION CRITERIA angiographic\n\n          1. Restenotic target lesion;\n\n          2. Need for treatment for more than one lesion in the same vessel;\n\n          3. Need for treatment with three or more lesions in the same procedure;\n\n          4. Target vessel diameter <2.5 mm or> 3.5 mm (visual);\n\n          5. Target lesion long not susceptible to treatment with a single stent to 29mm in\n             length, according to the judgment of the operator;\n\n          6. Lesion of the coronary artery unprotected ( > 50% stenosis);\n\n          7. Angiographic thrombus;\n\n          8. Target lesion in surgical graft;\n\n          9. Total occlusion (TIMI anterograde flow 0 or 1);\n\n         10. Ostial lesion;\n\n         11. The target lesion bifurcation with side branch that may require intervention during\n             the procedure, with or without stenting;\n\n         12. Injuries that are impossible to anticipate predilatation successfully or that is\n             necessary to use rotablator;\n\n         13. The target vessel with excessive tortuosity."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "165", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01856088", 
            "org_study_id": "Scitech 004"
        }, 
        "intervention": {
            "arm_group_label": [
                "Drug Eluting Stent", 
                "Drug eluting stent"
            ], 
            "description": "Site preparation acces should be performed as per standard hospital procedures It is recommended to cross the target lesion with 0,014 inch exchange-lenght guide wire. If necessary the involved lesion should be predilated with appropriately sized balloons using standard techniques. It is strongly encouraged that the Investigators use similar materials and techniques throughout the study to maintain consistency and standardization of care. A stent consists of an endovascular prosthesis with a metalic mesh structure that is implanted at the site of the artery blockage via catheterization procedure. The objective of stenting is to obtain an angiographic appearance of the expanded stent only outside the limits of the target vessel filled with contrast medium.", 
            "intervention_name": "Inspiron \u2122 stent eluting sirolimus or   Biomatrix\u2122  stent eluting biolimus", 
            "intervention_type": "Device", 
            "other_name": [
                "Drug eluting stent", 
                "Angiography"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Sirolimus", 
                "Everolimus"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Coronary artery", 
            "Drug eluting stent", 
            "thrombosis"
        ], 
        "lastchanged_date": "June 24, 2013", 
        "link": [
            {
                "description": "Sponsor site", 
                "url": "http://www.scitechmed.com"
            }, 
            {
                "description": "National Information System on Ethics in Research Involving Human", 
                "url": "http://portal2.saude.gov.br/sisnep"
            }, 
            {
                "description": "Site about the location thet wiil be done the study. Location where the principal investigator works.", 
                "url": "http://www.dantepazzanese.org.br"
            }
        ], 
        "location": [
            {
                "contact": {
                    "email": "npcardio@yahoo.com", 
                    "last_name": "Aline de Souza Bernardes Reis", 
                    "phone": "55 71 2203-8476"
                }, 
                "facility": {
                    "address": {
                        "city": "Salvador", 
                        "country": "Brazil", 
                        "state": "Bahia"
                    }, 
                    "name": "Hospital Santa Izabel"
                }, 
                "investigator": {
                    "last_name": "Adriano Dourado, Medicine", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "anapaula@intercath.com.br", 
                    "last_name": "Ana Paula Oliveira", 
                    "phone": "55 27 3346-2121"
                }, 
                "facility": {
                    "address": {
                        "city": "Cariacica", 
                        "country": "Brazil", 
                        "state": "ES"
                    }, 
                    "name": "Intercath Meridional"
                }, 
                "investigator": {
                    "last_name": "Bruno Moulin Machado, Medicine", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pesquisaclinica@encore.med.br", 
                    "last_name": "Mara Rubia Rocha", 
                    "phone": "55 62 3230-1825"
                }, 
                "facility": {
                    "address": {
                        "city": "Goi\u00e2nia", 
                        "country": "Brazil", 
                        "state": "Goi\u00e1s"
                    }, 
                    "name": "Encore - Cardiologia e Radiologia Intervencionista"
                }, 
                "investigator": {
                    "last_name": "Mauricio Prudete, Medicine", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pesquisa@hospitalcostantini.com.br", 
                    "last_name": "Danilo , Nursing", 
                    "phone": "55 41 3013-9266"
                }, 
                "facility": {
                    "address": {
                        "city": "Curitiba", 
                        "country": "Brazil", 
                        "state": "PR"
                    }, 
                    "name": "Hospital Cardiologico Costantini"
                }, 
                "investigator": {
                    "last_name": "Costantino Costantino, Medicine", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pesquisaclinica@cardiologia.org.br", 
                    "last_name": "Antonieta Moraes, Nursing", 
                    "phone": "55 51 3230-3678"
                }, 
                "contact_backup": {
                    "email": "pesquisaclinica@cardiologia.org.br", 
                    "last_name": "Silvia , Nursing", 
                    "phone": "55 51 3230-3678"
                }, 
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "Rio Grande do Sul"
                    }, 
                    "name": "Instituto de Cardiologia do Rio Grande do Sul"
                }, 
                "investigator": {
                    "last_name": "Rog\u00e9rio E. Gomes Sarmento Leite, Medicine", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "emiliamizuno@yahoo.com.br", 
                    "last_name": "Emilia Mizuno, Nursing", 
                    "phone": "55 11 50837001"
                }, 
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP"
                    }, 
                    "name": "Instituto de Assist\u00eancia M\u00e9dica ao Servidor Publico Estadual"
                }, 
                "investigator": {
                    "last_name": "George Ximenes Meireles, Medicine", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rviana@dantepazzanese.org.br", 
                    "last_name": "Renata Viana, Medicine", 
                    "phone": "55 11 5085-6325"
                }, 
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP"
                    }, 
                    "name": "Instituto Dante Pazzanese de Cardiologia"
                }, 
                "investigator": {
                    "last_name": "Alexandre Abizaid, Medicine", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "patricia.pereira@incor.usp.br", 
                    "last_name": "Patricia Pereira, Biomedicine", 
                    "phone": "55 11 2661-5377"
                }, 
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP"
                    }, 
                    "name": "Instituto do Cora\u00e7\u00e3o do Hospital das Cl\u00ednicas da Faculdade de Medicina da USP"
                }, 
                "investigator": {
                    "last_name": "Expedito E. Ribeiro da Silva, Medicine", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "marianijr@uol.com.br", 
                    "last_name": "Jos\u00e9 Mariani J\u00fanior, Medicine", 
                    "phone": "55 11 2176-7000"
                }, 
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP"
                    }, 
                    "name": "Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 Mariani J\u00fanior, Medicine", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "s.baradel@yahoo.com.br", 
                    "last_name": "Sandra Regina Bardel, nursing", 
                    "phone": "55 11 3345-2476"
                }, 
                "contact_backup": {
                    "email": "stefaniaenfermagem@hotmail.com", 
                    "last_name": "Stefania Rodrigues Pereira, Nursing", 
                    "phone": "55 11 3345-2476"
                }, 
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP"
                    }, 
                    "name": "Hospital Bandeirantes de S\u00e3o Paulo"
                }, 
                "investigator": [
                    {
                        "last_name": "Marcelo Cantarelli, Medicine", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Helio Castello, Medicine", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Stephanie Kitze"
                }, 
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil"
                    }, 
                    "name": "Hospital Santa Marcelina"
                }, 
                "investigator": {
                    "last_name": "Marco Antonio Perin", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Stents Coated With the Biodegradable Polymer on Their Faces and Elution of Sirolimus Abluminais Versus Elution Biolimus for the Treatment of Coronary Lesions Again - Randomized Destiny", 
        "overall_contact": {
            "email": "adriana.gouveia@cmsmedical.com.br", 
            "last_name": "Adriana Gouveia, nursing", 
            "phone": "55 11 98920-2999"
        }, 
        "overall_contact_backup": {
            "email": "patricia.pereira@incor.usp.br", 
            "last_name": "Patricia Pereira, Medicine", 
            "phone": "55 11 2661 5368"
        }, 
        "overall_official": {
            "affiliation": "Instituto do Cora\u00e7\u00e3o - Incor", 
            "last_name": "Pedro Lemos", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "For an accurate assessment of the stent conditions 9 months after implantation, a follow-up catheterization will be performed at the 9 months visit in order to measure the diameter of the artery at the stented site.\nA subgroup of 60 patients will be evaluated with volumetric intravascular ultrasound at 9 months. Also, a subgroup of 21 patients will be evaluated with optical coherence tomography at the end of the index procedure and 9 months.", 
            "measure": "Lumen Loss", 
            "safety_issue": "Yes", 
            "time_frame": "9 months after the procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01856088"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The clinical follow-up should be performed during the index procedure at 30 days, 4, 9, 12 months and 2, 3, 4, 5 years after the procedure, and should consist of an assessment of the angina status (according to the Canadian Cardiovascular Society Classification and the Braunwald for unstable angina) and major adverse cardiac avents and any interventional treatment (e.g: repeated targetlesion revascularization or recurrent ischemia)", 
            "measure": "Adverse Cardiac Events", 
            "safety_issue": "Yes", 
            "time_frame": "30 days, 4, 9, 12 months and 2, 3, 4, 5 years after the procedure."
        }, 
        "source": "Scitech Produtos Medicos Ltda", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Scitech Produtos Medicos Ltda", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}